🇺🇸 FDA
Patent

US 10434181

Oligomer-containing benzamide-based compounds

granted A61KA61K31/166A61K47/59

Quick answer

US patent 10434181 (Oligomer-containing benzamide-based compounds) held by Nektar Therapeutics expires Mon Oct 03 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Nektar Therapeutics
Grant date
Tue Oct 08 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 03 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
9
CPC classes
A61K, A61K31/166, A61K47/59, A61K47/60, A61P